Precision medicine -> the practice of treating diseases using insights gained from sequencing the human genome is an ...

Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...

Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

The conversation centred on the company’s latest developments and strategic direction in cancer therapies, with a particular ...

Gene expression leading to alterations in the DNA caused by asbestos exposure may explain the development of Malignant ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

The AI in precision medicine market is experiencing significant growth, driven by the increasing global prevalence of chronic and genetic disorders, which has heightened the demand for personalized ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Scientists discover unique insulin responses in each person, opening new paths for early diabetes detection and treatment.